Cite
Sweet DG, Turner M, Straňák Z, et al. A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome: two-year outcomes. J Matern Fetal Neonatal Med. 2020;1-5doi: 10.1080/14767058.2020.1863363.
Sweet, D. G., Turner, M., Straňák, Z., Plavka, R., Clarke, P., Stenson, B., Singer, D., Goelz, R., Fabbri, L., Varoli, G., Piccinno, A., Santoro, D., Del Buono, D., & Speer, C. P. (2020). A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome: two-year outcomes. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 1-5. https://doi.org/10.1080/14767058.2020.1863363
Sweet, David G, et al. "A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome: two-year outcomes." The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians vol. (2020): 1-5. doi: https://doi.org/10.1080/14767058.2020.1863363
Sweet DG, Turner M, Straňák Z, Plavka R, Clarke P, Stenson B, Singer D, Goelz R, Fabbri L, Varoli G, Piccinno A, Santoro D, Del Buono D, Speer CP. A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome: two-year outcomes. J Matern Fetal Neonatal Med. 2020 Dec 20;1-5. doi: 10.1080/14767058.2020.1863363. Epub 2020 Dec 20. PMID: 33345663.
Copy
Download .nbib